Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
cultivate(MD) Capital Fund II
Grand Rapids, Michigan, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
cultivate(MD) Capital Fund II, LP is a venture capital fund that invests in early-stage healthcare and medical device companies; it is an investment vehicle and does not itself develop therapeutics or run clinical trials.[1][2][6]
- Industry
- Investors
02
Partnerships
Portfolio and investment relationships with early-stage medical device and healthcare technology companies such as Embody, Imascap, Shoulder Innovations, HAPPE Spine and others via cultivate(MD) funds.
Beyond the preview
Go deeper on cultivate(MD) Capital Fund II.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cultivate(MD) Capital Fund II.